Source Search Page
clinicaltrialsarena.com > news
Arbele to move ahead with ARB202 gastrointestinal cancer trial
4+ hour, 17+ min ago —...from the Data Monitoring Committee (DMC) to continue the Phase I... ...The DMC, comprising independent experts, based its recommendation... ...Arbele chief medical officer Dr Dennis Wong said: “We are greatly... ...most comprehensive Company Profiles on the market, powered by GlobalData...
clinicaltrialsarena.com > news
AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial
4+ hour, 42+ min ago —...AstraZeneca and Daiichi Sankyo have announced that their therapy... ...Enhertu significantly improves progression-free survival in metastatic... ...AstraZeneca Oncology R&D executive vice-president Susan Galbraith... ...A total of 866 patients from Asia, Europe, North America, and South...
clinicaltrialsarena.com > news
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
5+ hour, 3+ min ago —...Gilead Sciences has received a US Food and Drug Administration (FDA... ...The expanded approval of Gilead’s Biktarvy was based on the Phase... ...of Health and Human Services (DHHS) perinatal guidelines.... ...GlobalData is the parent company of Clinical Trials Arena....
clinicaltrialsarena.com > news
EMA authorises AriBio's Phase III clinical trial for Alzheimer's
6+ hour, 28+ min ago —..., Denmark, France, Germany, Italy, Spain, and the Netherlands.... ...by submitting the below form AriBio chief clinical officer James Rock... ...most comprehensive Company Profiles on the market, powered by GlobalData...
clinicaltrialsarena.com > news
Allogene’s CAR T clinical trial advances with CIRM grant
6+ hour, 27+ min ago —...Institute for Regenerative Medicine (CIRM) to support the clinical... ...Allogene Therapeutics has received a grant of $15m from the California... ...CIRM therapeutics development vice-president Dr Abla Creasey said... ...In March 2022, ALLO-316 obtained the US Food and Drug Administration...
clinicaltrialsarena.com > news
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
3+ day ago —..., Agent Capital, Bioluminescence Ventures, and Double Point Ventures... ...included multiple US-based venture capital firms such as Google Ventures... ..., Germany, Italy, Spain, and the UK, as per the GlobalData... ...is the parent company of Clinical Trials Arena....
clinicaltrialsarena.com > news
FDA approves Freedom Biosciences’s TRD treatment trial
3+ day ago —...The US Food and Drug Administration (FDA) has approved Freedom Biosciences... ...’s investigational new drug (IND) application for FREE001, enabling... ...and PsyMed Ventures founder Dina Burkitbayeva.... ...Freedom Biosciences was co-founded by Yale University psychiatry...
clinicaltrialsarena.com > news
Caliway Biopharmaceuticals’ cellulite study meets endpoints
3+ day ago —...Taiwanese biopharmaceutical company Caliway Biopharmaceuticals has... ...Caliway Biopharmaceuticals said the study demonstrated statistically... ...the Australian Bellberry Human Research Ethics Committee to begin... ...from the US Food and Drug Administration (FDA)....
clinicaltrialsarena.com
Key opinion leaders on GLP-1 receptor agonist clinical trial design
2+ day ago —...Speaking to leading data and analytics company GlobalData, several... ...and what happens to your physical function with some of these drugs... ...According to a high-prescribers survey conducted by GlobalData, a...
clinicaltrialsarena.com > news
Exeliom to focus on gastric cancer landscape with immune modulating drug
3+ day ago —..., CEO of Exeliom, told the Clinical Trials Arena.... ...Paris-based Exeliom Biosciences will focus Phase III efforts of its... ..., Italy, Spain, UK, Japan, and South Korea) was valued at... ...carcinoma, led by the Centre Eugène Marquis of Rennes....